Published July 29, 2026 | Version v1

Cis-eQTL nominal summary statistics in healthy gut (7 over 13)

Description

The description of these files is available at https://zenodo.org/records/21457760.

Files

Files (47.5 GB)

Name Size
md5:154d7d75c35ed79a6d63a77ae0db49e7
1.6 GB Download
md5:a3f3296d7f876bcb3bd420a0e137dd4b
1.4 GB Download
md5:1e14b36b7350345acdad60dbbb034415
1.7 GB Download
md5:729e8f078e5bf014729f35c3f682deb0
1.7 GB Download
md5:db764eb470db406a46cfe07cea34c079
1.6 GB Download
md5:33134bbb575be762c29de53830b1bf90
1.6 GB Download
md5:c171624c2b76b286a9ed3ddf7e137c89
1.6 GB Download
md5:711e9716a487d48a1bb4dd0672940fe4
1.6 GB Download
md5:384cf8035c0e3d22e1b330baeccf1192
1.5 GB Download
md5:653dfb50a3b4bd5105318c70cd6c233d
1.6 GB Download
md5:f0d2e3193cf52d2de0878eb8174abc2b
1.6 GB Download
md5:b640b74a05bfa5b4edaab28cbe9eef34
1.5 GB Download
md5:f72dc2612dba499e816d6e20d8751720
1.4 GB Download
md5:d04184e8cadc206d92a77d5b104824ce
1.7 GB Download
md5:a863bfde18cd104082aadcccb578277b
1.7 GB Download
md5:542636a4534a1f55c88dda2c11c6df8f
1.5 GB Download
md5:3e349495cd37d3e417657c3610868bdb
1.6 GB Download
md5:82d05523ec66c700e2f567d26e02ca3d
1.5 GB Download
md5:8ef46609c5d9358965e85a1e50384384
1.6 GB Download
md5:0132ca57797b2831d0b4640521e14640
1.5 GB Download
md5:cc27973dcc5931713763651315b46bb2
1.5 GB Download
md5:2c49bab798be160839cb178a0de771d8
1.6 GB Download
md5:4bd966776cffdba54905ec157e815ad3
1.6 GB Download
md5:2e6ca9b39d230ed1b8ee9f2e6e9779ea
1.6 GB Download
md5:6bcd121c86c2c230b818c97a7ed7142c
1.6 GB Download
md5:6d1f24167d74089cb269cbda0bb1c49d
1.6 GB Download
md5:6d6359e928fa0f1ce451eb7bcb393846
1.5 GB Download
md5:fbd73629fe6580d5c598abd2a3cdc683
1.7 GB Download
md5:705f5bda999bb860985d37ca9ee66d8d
1.7 GB Download
md5:e805f84465e502902d6c22b6b005016a
1.5 GB Download

Additional details

Related works

Is supplement to
10.5281/zenodo.21457760 (DOI)

References

  • Perée et al., Nature Communications (2026). Integrated cell type-specific cis-eQTL analyses of blood and gut identifies ~25 thousand regulatory modules, matching eQTL for 140 IBD risk loci, and entrectinib as possible repurposing candidate.